Citigroup Maintains Buy on Intuitive Surgical, Raises Price Target to $400
Portfolio Pulse from richadhand@benzinga.com
Citigroup analyst Joanne Wuensch maintains a Buy rating on Intuitive Surgical (NASDAQ:ISRG) and raises the price target from $317 to $400.
July 11, 2023 | 2:24 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Citigroup maintains a Buy rating on Intuitive Surgical and raises the price target from $317 to $400, which could lead to a positive impact on the stock.
The raised price target by Citigroup indicates a positive outlook for Intuitive Surgical. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100